China Biotech CEO Interview with Hua Medicine’s Li Chen

Citeline Podcasts
01/09/2023 36 min
China Biotech CEO Interview with Hua Medicine’s Li Chen

Listen "China Biotech CEO Interview with Hua Medicine’s Li Chen"

Descargar episodio Ver en sitio original

Episode Synopsis

Hua Medicine’s founder and CEO Li Chen discusses with host Brian Yang about its new product launch for dorzagliatin, glucokinase activator for type 2 diabetes in China, partnership with Bayer, and plans to get reimbursed through National Reimbursement Drug List.
https://scrip.pharmaintelligence.informa.com/SC148981/Hua-Medicines-Chen-On-Product-Launch-Bayer-Partnership-And-Reimbursement

More episodes of the podcast Citeline Podcasts

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 10/11/2025
Scrip's Five Must-Know Things - Nov. 10, 2025 10/11/2025
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center 07/11/2025
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology 06/11/2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 04/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025 04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform 31/10/2025
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine 31/10/2025
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space? 31/10/2025
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast) 31/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA